Chemours <CC.N>: BMO Cuts Target Price to $18 From $26
CC•Related News
Brief-Qtrex Quantum Ltd In Discussions With A US Department Of Defense’s Research Laboratory To Establish A Joint Quantum Development Program
QTEX•
Sharplink Gaming stakes $200 million ETH via Lido in treasury yield push
SBET•
Artelo Biosciences Q2 net loss narrows as R&D expenses fall
ARTL•
Aimei Health Q2 FY26 net loss widens to $83,144; six-month net loss totals $37,704
AFJK•
Ondas beats Q2 revenue estimates, raises 2026 revenue target
ONDS•